1. Preimplantation Genetic Diagnosis Market Analysis And Segment Forecasts To 2024 Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

2. Preimplantation Genetic Diagnosis Market Analysis And Segment Forecasts To 2024 Global preimplantation genetic diagnosisis market expected to reach USD 96.8 million by 2024, according to a new report by Grand View Research, Inc. This expected growth in demand can be ascribed to the growing incidence of inherited single gene associated and late onset genetic disorders. Browse the report: http://www.orbisresearch.com/reports/index/preimplantation-genetic- diagnosis-market-analysis-by-type-application-and-segment-forecasts-to-2024http://www.orbisresearch.com/reports/index/preimplantation-genetic- diagnosis-market-analysis-by-type-application-and-segment-forecasts-to-2024 Ongoing introduction of advancements in in-vitro fertilization (IVF) methods are key factors that have a positive impact on the growth of this market. Incorporation of novel algorithms pertaining to genetic diagnosis using NGS technology are expected to fuel demand in the coming years. Demand for successful embryo implantation in couples who are detected with certain chromosomal aberrations or fertility problems are also factors anticipated to boost growth in demand over the forecast period. Chromosomal abnormalities accounted for over 36% of the revenue generated in 2015. This large share can be attributed to growing usage of PGD techniques for detection of aneuploidies that are observed in higher aged maternal patients. Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

3. Preimplantation Genetic Diagnosis Market Analysis And Segment Forecasts To 2024 North America dominated the market in 2015, with revenue estimated at over USD 35 million in 2015. Presence of sophisticated healthcare infrastructure, rising aneuploidy, and infertility rates, favorable government initiatives with respect to genetic diagnosis and its application in IVF are major factors driving growth of this region. Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/112789http://www.orbisresearch.com/contacts/request-sample/112789 Asia Pacific is expected to witness lucrative growth from 2016 to 2024 due to the availability of cost- effective PGD procedures coupled with rapidly rising healthcare R&D investment, and growing medical expenditures in emerging economies of India and China. Key participants of the preimplantation genetic diagnosis market include Genesis Genetics, LabCorp, Natera, Quest Diagnostics, Genea, Genzyme Corporation, Reproductive Genetics Institute, and F. Hoffman La Roche Ltd. Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

4. About Us: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors accross the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients. Contact Information: 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A. Phone No.: +1 (214) 884-6817 enquiry@orbisresearch.com sales@orbisresearch.com Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com Preimplantation Genetic Diagnosis Market Analysis And Segment Forecasts To 2024